H.R. 4348 · 119th Congress · Health
To reauthorize the Kay Hagan Tick Act, and for other purposes.
Reauthorizes CDC vector-borne disease prevention activities and grants through fiscal year 2030. AI-read
- IntroducedJul 10, 2025 Done
- CommitteeReported Jul 2, 2026 Done
- House floorPassed by voice vote · Jul 20, 2026 Done
- Senate floorAwaiting vote Current stage
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill reauthorizes through FY2030 activities of the Centers for Disease Control and Prevention to address vector-borne diseases (e.g., diseases spread by bites from ticks or mosquitoes). These activities include (1) a national strategy, (2) grants for regional centers of excellence, and (3) cooperative agreements with state, local, and tribal health departments to increase capacity for preventing and responding to vector-borne diseases.
Congressional Research Service · summary of “Reported to House” version · Jul 2, 2026
Who lobbies on it
No lobbying filing on file names H.R. 4348.
Organizations that named H.R. 4348 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Source: Senate lobbying disclosures (LD-2) from lda.gov; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
16 actions · newest first- Jul 21, 2026Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 463.
- Jul 20, 2026Motion to reconsider laid on the table Agreed to without objection.
- Jul 20, 2026On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4640)
- Jul 20, 2026Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4640)
Show all 16 actionsShow fewer
- Jul 20, 2026DEBATE - The House proceeded with forty minutes of debate on H.R. 4348.
- Jul 20, 2026Considered under suspension of the rules. (consideration: CR H4640-4642)
- Jul 20, 2026Mr. Guthrie moved to suspend the rules and pass the bill.
- Jul 2, 2026Placed on the Union Calendar, Calendar No. 630.
- Jul 2, 2026Reported by the Committee on Energy and Commerce. H. Rept. 119-725.
- May 21, 2026Ordered to be Reported by the Yeas and Nays: 48 - 0.
- May 21, 2026Committee Consideration and Mark-up Session Held
- May 13, 2026Forwarded by Subcommittee to Full Committee by Voice Vote.
- May 13, 2026Subcommittee Consideration and Mark-up Session Held
- Jul 10, 2025Referred to the House Committee on Energy and Commerce.
- Jul 10, 2025Referred to the Subcommittee on Health.
- Jul 10, 2025Introduced in House
What members said about it
-
Last night, the U.S. House of Representatives overwhelmingly approved legislation to provide $150 million over five years in continued funding for Lyme disease research at the U.S. Centers for Disease Control and Prevention (CDC), sending…
“My colleagues will recall that our distinguished colleague, North Carolina Senator Kay Hagan, suffered a tick bite and died in 2019 from encephalitis caused by Powassan virus—the current law and reauthorization is named in her honor.”
-
Rep. Chris Smith (R-NJ), the founder and Co-Chair of the Congressional Lyme and Tick-Borne Disease Caucus, applauded Secretary Robert F. Kennedy Jr.’s announcement today that the U.S. Department of Health and Human Services (HHS) is…
“Under President Trump and Secretary Kennedy’s bold leadership, the HHS is taking important steps towards addressing and mitigating the national public health emergency caused by Lyme disease and other tick-borne illnesses over the past several decades.”
-
Congressman Griffith’s Weekly E-Newsletter 7.24.26
Lawmakers take actions on various issues to make a difference.
-
Today, the U.S. House of Representatives approved legislation authored by Rep. Chris Smith (R-NJ) to provide $150 million over five years in continued funding for Lyme disease research at the U.S. Centers for Disease Control and Prevention…
“‘Lyme disease remains one of the Nation’s fastest-growing vector-borne health threats. More than 476,000 Americans are diagnosed with Lyme disease each year, and recent data show emergency room visits for tick bites reached their highest springtime level in nearly a decade.’”
-
New Jersey Congressman Chris Smith (R, NJ-04) is welcoming a series of new federal initiatives aimed at strengthening the nation’s response to Lyme disease, including expanded research funding, prevention efforts, and support for innovative…
“Millions of Americans battling Lyme disease and other tick-borne illnesses have spent years searching for answers, treatment, and support.”
-
Rep. Chris Smith (R-NJ), Co-Chair of the Congressional Lyme and Tick-Borne Disease Caucus, praised U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. for his leadership and new, groundbreaking investments in…
“I am very grateful to Secretary Kennedy for voicing his strong support for provisions of my bill to reauthorizes the Kay Hagan Tick Act and help improve the quality of life and long-term health outcomes for Lyme patients throughout the country.”
-
During their full committee markup today, the House Committee on Energy and Commerce unanimously approved two critical public health reauthorization bills authored by Rep. Chris Smith (R-NJ)—HR 4348, the Kay Hagan Tick Act, and HR 5160, the…
“Now that these critical, life-enhancing bills have passed out of the Energy & Commerce Committee, we are one step closer to getting them across the finish line and onto President Trump’s desk for his signature.”
-
Tonko Cheers Advance of Key Health Priorities Out of House Committee
Congressman Paul D. Tonko (NY-20) today celebrated the advance of several priorities he champions impacting the health and wellbeing of American families out of the full Energy and Commerce Committee today.
“Over my years in Congress, I have remained laser focused on advancing commonsense, meaningful legislation that bolsters the health and wellbeing of the American people.”
-
Two critical public health reauthorization bills authored by Rep. Chris Smith (R-NJ)—HR 5160, the Stem Cell Therapeutic and Research Reauthorization Act of 2025, and HR 4348, the Kay Hagan Tick Act—today passed out of the House Committee on…
“I am grateful to the Subcommittee on Health, especially Chairman Morgan Griffith (R-VA), for advancing these critical, life-enhancing bills to assist the millions of Americans suffering from chronic health conditions.”
-
Riley Co-Sponsors Bipartisan Bill to Fight Lyme and Tick-Borne Diseases
Congressman Josh Riley (NY-19) announced today that he is co-sponsoring the bipartisan Kay Hagan Tick Act Reauthorization (H.R. 4348), a bill to step up the fight against Lyme disease and other tick-borne illnesses across Upstate New York.
“Too many families in Upstate New York know deeply and personally what it’s like to deal with tick-borne diseases.”
-
Smith unveils bill to secure critical research fundingTICK Act reintroduced in the House
New legislation to reauthorize the nation’s federal efforts to fight Lyme disease was announced yesterday on Capitol Hill.
“Lyme and other tick-borne diseases are exploding in the United States, particularly in my home state of New Jersey, where the CDC recorded over 7,000 new cases in 2023 alone.”